Literature DB >> 1908974

Hypoglossal-facial nerve interpositional-jump graft for facial reanimation without tongue atrophy.

M May1, S M Sobol, S J Mester.   

Abstract

The hemitongue paralysis that occurs as a result of a classic hypoglossal-facial nerve crossover procedure can result in profound functional deficits in speech, mastication, and swallowing. The procedure is not an option in patients with bilateral facial paralysis or those at risk for combined cranial nerve deficits. To address some of the drawbacks and limitations of this classic procedure, we developed the hypoglossal-facial nerve interpositional jump graft (12-7 jump graft) procedure. This procedure involves interposing a nerve graft between a partially severed but functionally intact twelfth cranial nerve and the degenerated seventh cranial nerve, and is often combined with other reanimation procedures. To date, we have performed 33 12-7 jump graft procedures in 30 patients (three were treated for bilateral facial paralysis); this report describes the procedure and its indications, and details the results of 23 procedures performed in 20 patients for whom 24-month follow-up data are available. Twelfth nerve deficits occurred in only three patients in this report. Recovery of facial function began between 3 and 24 months postoperatively. Facial tone and symmetry were achieved in every patient, no patient had significant mass movement, and 13 patients (two of whom were treated for bilateral facial paralysis) had excellent and three had superb restoration of facial movement. These results show the 12-7 jump graft to be a valuable adjunct for facial reanimation in selected patients.

Entities:  

Mesh:

Year:  1991        PMID: 1908974     DOI: 10.1177/019459989110400609

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  28 in total

1.  [Diagnostics of diseases and the function of the facial nerve].

Authors:  O Guntinas-Lichius; C Sittel
Journal:  HNO       Date:  2004-12       Impact factor: 1.284

Review 2.  [Rehabilitation options for lesions of the facial nerve].

Authors:  O Guntinas-Lichius
Journal:  HNO       Date:  2007-08       Impact factor: 1.284

Review 3.  Approaches for neural tissue regeneration.

Authors:  Loïc Binan; Abdellah Ajji; Gregory De Crescenzo; Mario Jolicoeur
Journal:  Stem Cell Rev Rep       Date:  2014-02       Impact factor: 5.739

4.  Reconstruction of complex defects of the extracranial facial nerve: technique of "the trifurcation approach".

Authors:  Dirk Beutner; Maria Grosheva
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-04-04       Impact factor: 2.503

Review 5.  [Surgical indications and complications management in vestibular schwannoma].

Authors:  S Rosahl; D Eßer
Journal:  HNO       Date:  2017-05       Impact factor: 1.284

Review 6.  [Update on diagnostics and microsurgical treatment of vestibular schwannoma].

Authors:  F H Ebner; M Tatagiba
Journal:  Nervenarzt       Date:  2019-06       Impact factor: 1.214

7.  Direct Facial-to-Hypoglossal Neurorrhaphy with Parotid Release.

Authors:  J Thomas Roland; Karen Lin; Lee M Klausner; Philip J Miller
Journal:  Skull Base       Date:  2006-05

8.  Morphology of experimentally denervated and reinnervated rat facial muscle. I. Histochemical and histological findings.

Authors:  D S Tews; H H Goebel; I Schneider; A Gunkel; E Stennert; W F Neiss
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

9.  Facial reanimation after facial nerve injury using hypoglossal to facial nerve anastomosis: the gruppo otologico experience.

Authors:  Sami Tanbouzi Husseini; David Victor Kumar; Giuseppe De Donato; Tamama Almutair; Mario Sanna
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2012-01-07

10.  Differences in glial, synaptic and motoneuron responses in the facial nucleus of the rat brainstem following facial nerve resection and nerve suture reanastomosis.

Authors:  O Guntinas-Lichius; W F Neiss; A Gunkel; E Stennert
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.